期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非小细胞肺癌个体化治疗的靶向分子检测 被引量：28

下载PDF
导出
摘要 非小细胞肺癌（non—small cell lungcancer，NSCLC）的个体化治疗是目前肿瘤研究领域的热点之一。
作者 刘标 周晓军
机构地区 南京大学医学院临床学院/南京军区南京总医院病理科
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第8期831-837,共7页 Chinese Journal of Clinical and Experimental Pathology
关键词 肺肿瘤 腺癌 分子 靶向
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1Pirker R, Herth F J F, Kerr K, et al. Consensus for EGFR muta- tion testing in non-small cell lung cancer: results from a european workshop[ J]. J Thorae Oncol, 2010,5 (10) : 1706 - 13.
  • 2Ellis P M, Blais N, Soulieres D, et al. A systematic review and canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer [ J ]. J Thorac Oncol, 2011,6(8) :1379 -91.
  • 3Saho-Tellez M, Tsao M S, Shih J Y, et al. Clinical and testing protocols for the analysis of epidermal growth factor receptor muta- tions in east asian patients with non-small cell lung cancer : a combined clinical-molecular pathological approach [ J ]. J Thorac Oncol,2011,6 ( 10 ) : 1663 - 9.
  • 4中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识[J].中华病理学杂志,2011,40(10):700-702. 被引量：64
  • 5Pirker R, Pereira J R, von Pawel J, et al. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer : analysis of data from the phase 3 FLEX study[J]. Lancet Oncol, 2012,13 ( 1 ) :33 -42.
  • 6Varella-Garcia M, Diebold J, Eberhard D A, et al. EGFR fluo- rescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer[ J]. J Clin Pathol, 2009,62( 11 ) :970 -7.
  • 7Soda M, Choi Y L, Enomoto M, et al. Identification of the trans- forming EMIA-ALK fusion gene in non-small-cell lung cancer[ J ]. Nature, 2007 (7153) ,448:561 - 6.
  • 8Zhang X C, Zhang S, Yang X N, et al. Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression[ J]. Mol Cancer, 2010,9 : 188.
  • 9Yang J, Zhang X, Su J, et al. Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer[ J]. J Clin Oncol,2011,29 (Suppl) : 10517 [ Abstr ].
  • 10Mino-Kenudson M, Chirieac L R, Law K, et al. A novel, highly sensitive antibody allows for the routine detection of ALK-rear- ranged lung adenocarcinomas by standard immunohistochemistry [J]. ClinCancerRes, 2010,16(5) :1561-71.

二级参考文献7

共引文献63

同被引文献234

  • 1吴洪斌.吉非替尼不良反应的临床表现及其处理[J].药物不良反应杂志,2006,8(1):28-30. 被引量：44
  • 2董强刚,韩宝惠,黄进肃,杨立民,黄建,赵春英,卢丽琴.176例非小细胞肺癌的EGFR基因突变分析[J].中华肿瘤杂志,2006,28(9):686-690. 被引量：53
  • 3任学群,李宜雄,陈善正,胡国潢,应娇茜,李劲东,裴海平,陈志康,汤恢焕,吕新生.胰十二指肠切除术后胰瘘的危险因素[J].中国普通外科杂志,2006,15(10):772-776. 被引量：45
  • 4高凌燕,屠锡德,周建平.纳米粒给药系统制备的研究进展[J].药学与临床研究,2007,15(3):179-183. 被引量：9
  • 5Dietel M, Sers C. Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review[J]. Virchows Arch, 2006, 448(6):744-755.
  • 6Walk EE. The role of pathologists in the era of personalized medicine[J]. Arch Pathol Lab Med, 2009, 133(4):605-610.
  • 7Giordano TJ. Molecular profiling and personalized predictive pathology: challenge to the academic surgical pathology community[J]. Am J Surg Pathol, 2006, 30(3):402-404.
  • 8Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO classification of tumours of the breast[M]. 4th Edition. Lyon, France: IARC Press, 2012; 14-31.
  • 9Varella-Garcia M, Diebold J, Eberhard DA, et al. EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer[J]. J Clin Pathol, 2009, 62(11):970-977.
  • 10Brugger W, Thomas M. EGFR-TKI resistant non-small cell lung cancer(NSCLC):New developments and implications for future treatment[J]. Lung Cancer, 2012, 77(1):2-8.

引证文献28

二级引证文献162

临床与实验病理学杂志
2012年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部